AstraZeneca’s New Medicines Buoy Second-Quarter Results

(Bloomberg) -- AstraZeneca Plc’s newer products are giving the company a lift, helping profit beat estimates in the second quarter.

Bloomberg Quint

Add BloombergQuint App to Home screen.